Hite Christopher insider trades

Hite Christopher has filed 16 Form 4s with the SEC that we hold, for Royalty Pharma plc (RPRX) (EVP & Chairman, Partnering), Kailera Therapeutics, Inc. (KLRA) (Director), Vera Therapeutics, Inc. (VERA) (Director) and XLRN (Director). Across all of them we count 0 purchases worth $0 and 9 sales worth $27.4M reported on Form 4. In the last 12 months: 0 purchases ($0) and 9 sales ($27.4M). The largest single trade was a sale of 117,592 shares of Royalty Pharma plc worth $6.4M, dated 2026-06-23. Of 2 sales filed since we began reading the 10b5-1 checkbox, 2 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-11-22 and the latest 2026-09-24.